Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Sanofi
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Virginia Commonwealth University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
University of Maryland, Baltimore
Montefiore Medical Center
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
University of Washington
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
Fred Hutchinson Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute